According to GlaxoSmithKline's latest financial reports the company's total liabilities are $57.22 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $58.82 B | -3.03% |
2022-12-31 | $60.66 B | -22.2% |
2021-12-31 | $77.96 B | -4.06% |
2020-12-31 | $81.27 B | 1.05% |
2019-12-31 | $80.42 B | 16.49% |
2018-12-31 | $69.04 B | -3.42% |
2017-12-31 | $71.48 B | 6.97% |
2016-12-31 | $66.83 B | 1.19% |
2015-12-31 | $66.04 B | 18.78% |
2014-12-31 | $55.60 B | -1.65% |
2013-12-31 | $56.53 B | 0.67% |
2012-12-31 | $56.15 B | 12.24% |
2011-12-31 | $50.03 B | -0.23% |
2010-12-31 | $50.14 B | -3.52% |
2009-12-31 | $51.97 B | 14.12% |
2008-12-31 | $45.54 B | 8.57% |
2007-12-31 | $41.94 B | 34.31% |
2006-12-31 | $31.23 B | -7.42% |
2005-12-31 | $33.73 B | 6.56% |
2004-12-31 | $31.66 B | 14.27% |
2003-12-31 | $27.70 B | 47.85% |
2002-12-31 | $18.74 B | 10.1% |
2001-12-31 | $17.02 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Novartis NVS | $54.57 B | -4.62% | ๐จ๐ญ Switzerland |
Pfizer PFE | $137.21 B | 139.78% | ๐บ๐ธ USA |
Sanofi SNY | $57.61 B | 0.68% | ๐ซ๐ท France |
Merck MRK | $69.04 B | 20.65% | ๐บ๐ธ USA |
AstraZeneca AZN | $64.79 B | 13.23% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | $35.35 B | -38.22% | ๐ฎ๐ฑ Israel |
Dynavax Technologies
DVAX | $0.37 B | -99.34% | ๐บ๐ธ USA |